1. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis;Song;Lancet Glob Health,2019
2. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Gerhard-Herman;Circulation,2017
3. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients;Yusuf;N Engl J Med,2000
4. Telmisartan, ramipril, or both in patients at high risk of vascular events;Buchner;N Engl J Med,2008
5. Predictors of underutilization of medical therapy in patients undergoing endovascular revascularization for peripheral artery disease;Altin;Cardiovascular Interventions,2020